“Being overweight, you automatically have 10 of the 11 risk factors, because being overweight lowers blood flow, accelerates ...

Alzheimer’s disease continues to rise as one of the most pressing health challenges facing aging populations today. It ...

While dementia and Alzheimer’s disease are terms that are often used interchangeably, they don’t mean the same thing.

The research looked specifically at blood stem cells, which live in the bone marrow and make different types of blood cells.

The benefit-risk balance is tipping more in favor of Eli Lilly’s Kisunla in early Alzheimer’s disease as the FDA approves a ...

Women are twice as likely to suffer from Alzheimer’s as men. Scientists have figured out why - One in three older Americans ...

The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 ...

UCLA's study identifies distinct Alzheimer's disease trajectories, emphasizing the role of shared risk factors in early detection and targeted interventions.

The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...

UCLA Health researchers mapped four distinct pathways leading to Alzheimer’s disease using electronic health records.   The ...

Dr. Marty Levine explains more about the disease and the support that's available for patients. Sponsored by Optum Care ...

Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...